Eli Lilly and Company

GPS Pharmacovigilance Strategy Leader

United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should possess a Bachelor’s degree in business or a related field, and a minimum of 7 years of experience in the pharmaceutical, pharmacovigilance, or another highly regulated industry. Furthermore, they should have at least 5 years of experience leading large, enterprise-wide transformation initiatives.

Responsibilities

The Sr. Director GPS Strategy will be responsible for developing and executing strategic initiatives to advance the GPS organization, overseeing an integrated Global Patient Safety transformation agenda emphasizing innovation and simplification. This includes developing and monitoring a change agenda for Global Patient Safety, conducting strategic planning, and managing large-scale transformation initiatives aligned with the company’s overall objectives. The role also entails leading the development of the overall transformation strategy and roadmap, managing stakeholder relationships, establishing governance frameworks, tracking KPIs, providing people and technical leadership, and continuously generating new ideas and programs to drive continuous improvement and innovation across LRL, while monitoring external regulatory and industry direction.

Skills

Strategic Planning
Transformation Management
Project Management
Change Management
Leadership
Global Patient Safety

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI